Related Experiment Video

Updated: Aug 11, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development

Shunbin Xiong1, Carolyn S Van Pelt, Ana C Elizondo-Fraire

  • 1Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, 77030, USA.

Proceedings of the National Academy of Sciences of the United States of America
|February 24, 2006
PubMed

Insights

Mice lacking Mdm2 or Mdm4 in the central nervous system (CNS) show severe developmental defects, highlighting the crucial, independent roles of Mdm2 and Mdm4 in regulating p53.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Mdm2 and Mdm4 are critical regulators of the tumor suppressor p53.
  • Loss of Mdm2 or Mdm4 results in p53-dependent embryonic lethality.
  • The redundant or independent functions of Mdm2 and Mdm4 in specific cell types remain unclear.

Purpose of the Study:

  • To investigate the redundant and independent roles of Mdm2 and Mdm4 in the central nervous system (CNS).
  • To determine the consequences of Mdm2 and Mdm4 loss on CNS development in a cell-type-specific manner.
  • To elucidate the gene dosage effects of Mdm2 and Mdm4 on CNS development.

Main Methods:

  • Utilized conditional alleles of Mdm2 and Mdm4.
  • Generated neuronal-specific Cre transgenic mice to delete Mdm2 and Mdm4 in the CNS.
  • Analyzed embryonic phenotypes, including apoptosis and cell cycle arrest.
  • Assessed the impact of p53 deletion on Mdm2/Mdm4 loss-induced phenotypes.

Main Results:

  • Mice lacking CNS Mdm2 exhibited hydranencephaly by embryonic day 12.5 due to apoptosis.
  • Mice lacking CNS Mdm4 displayed proencephaly by embryonic day 17.5, linked to cell cycle arrest and apoptosis.
  • Combined deletion of Mdm2 and Mdm4 led to an earlier and more severe CNS phenotype.
  • A gene dosage effect was observed, with loss of three Mdm alleles accelerating CNS defects.
  • All observed phenotypes were rescued by the concurrent deletion of p53.

Conclusions:

  • Mdm2 and Mdm4 play essential, partially redundant roles in inhibiting p53 within the CNS.
  • Mdm4 has a significant function independent of Mdm2 in controlling p53 activity in vivo.
  • These findings underscore the critical importance of Mdm2 and Mdm4 in normal CNS development and p53 regulation.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...